Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study

Authors

Patrício Soares-Da-Silva, BIAL
Heinz Reichmann, Technische Universität Dresden
Andrew Lees, University College London
José Francisco Rocha, BIAL
Diogo Magalhães, BIAL
Camille Carroll, Peninsula Medical School

ORCID

• Camille Carroll: 0000-0001-7472-953X

DOI Link

10.1186/s40035-020-00187-1

DOI

10.1186/s40035-020-00187-1

Publication Date

2020-01-01

Publication Title

Translational Neurodegeneration

Volume

9

Issue

1

Embargo Period

2020-06-06

Recommended Citation

Soares-Da-Silva, P., Reichmann, H., Lees, A., Rocha, J., Magalhães, D., & Carroll, C. (2020) 'Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study', Translational Neurodegeneration, 9(1). Available at: 10.1186/s40035-020-00187-1